EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epstein-Barr Virus: Structure, Pathogenesis, Diagnosis, and Management of Associated Diseases

I. H. Iheukwumere, C. M. Iheukwumere, B. C. Unaeze, V. E Ike, H. C. Nnadozie, S. O. Onyema

IPS Journal of Basic and Clinical Medicine · 2023

DOI: 10.54117/ijbcm.v2i4.23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IPS Journal of Basic and Clinical Medicine, 2023. Verfasst von I. H. Iheukwumere und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV), or human herpesvirus 4, is a ubiquitous gammaherpesvirus that establishes lifelong infection in over 90% of the global adult population. It is characterized by a complex structure, including an envelope with glycoproteins crucial for cell entry, a tegument protein layer, and an icosahedral capsid surrounding a linear double-stranded DNA genome approximately 172 kb in size. Primary transmission occurs via saliva, earning it the nickname "the kissing disease." While initial infection in childhood is often asymptomatic, infection in adolescents and young adults frequently results in infectious mononucleosis, presenting with fever, pharyngitis, lymphadenopathy, and fatigue. A significant aspect of EBV's pathogenesis is its ability to establish latent infection in B-lymphocytes, with periodic reactivation. This latent state is a key driver of its association with several malignancies, including Burkitt lymphoma, Hodgkin lymphoma, nasopharyngeal carcinoma, and post-transplant lymphoproliferative disorder (PTLD). Diagnosis primarily relies on serological tests detecting antibodies against viral capsid antigen (VCA), early antigen (EA), and nuclear antigen (EBNA), with molecular methods like PCR used for viral load quantification, especially in immunocompromised patients. Treatment for most cases of infectious mononucleosis is supportive, as no specific antiviral therapy is routinely recommended. Management focuses on symptom relief with analgesics, antipyretics, and rest. For severe or complicated cases, such as PTLD, strategies include immunosuppression reduction and immunotherapy. Prevention remains centered on hygiene practices to limit salivary exposure, as no licensed vaccine is yet available. Ongoing research into vaccines and immunotherapies is critical for improving outcomes for EBV-associated diseases.

Zitieren

APA

Iheukwumere, I. H., Iheukwumere, C. M., Unaeze, B. C., Ike, V. E., Nnadozie, H. C., & Onyema, S. O. (2023). Epstein-Barr Virus: Structure, Pathogenesis, Diagnosis, and Management of Associated Diseases. IPS Journal of Basic and Clinical Medicine. https://doi.org/10.54117/ijbcm.v2i4.23

Vancouver

Iheukwumere IH, Iheukwumere CM, Unaeze BC, Ike VE, Nnadozie HC, Onyema SO. Epstein-Barr Virus: Structure, Pathogenesis, Diagnosis, and Management of Associated Diseases. IPS Journal of Basic and Clinical Medicine. 2023. doi:10.54117/ijbcm.v2i4.23

BibTeX
@article{Iheukwumere2023,
  author = {Iheukwumere, I. H. and Iheukwumere, C. M. and Unaeze, B. C. and Ike, V. E and Nnadozie, H. C. and Onyema, S. O.},
  title = {Epstein-Barr Virus: Structure, Pathogenesis, Diagnosis, and Management of Associated Diseases},
  journal = {IPS Journal of Basic and Clinical Medicine},
  year = {2023},
  doi = {10.54117/ijbcm.v2i4.23}
}
Kostenlos starten →